Screener
Ligand Pharmaceuticals LGND Invested capital
Discontinued — last reported Q2 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Ligand Pharmaceuticals’s reported figures.
The source filing: Ligand Pharmaceuticals’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 7, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000886163-26-000044
FAQ
- What is Ligand Pharmaceuticals's invested capital?
- Ligand Pharmaceuticals (LGND) reported invested capital of $1.09B in Q2 2026.
- How has Ligand Pharmaceuticals's invested capital changed year-over-year?
- Ligand Pharmaceuticals's invested capital increased by 42.7% year-over-year, from $765.39M to $1.09B.
- What is the long-term trend for Ligand Pharmaceuticals's invested capital?
- Over 5 years (2020 to 2025), Ligand Pharmaceuticals's invested capital has grown at a 4.4% compound annual growth rate (CAGR), from $682.39M to $847.64M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Ligand Pharmaceuticals's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude